RxDoctor Payments Data

Brent Frame, DPM

Podiatrist · Albuquerque, NMNPI 1407879703

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.9% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Stryker at 26.7% of the total.

$2,814in general payments, 2019–2025

Across 98 payments — averaging $28.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$751
  • Smith+Nephew$531
  • Treace Medical Concepts, Inc.$409
  • Kerecis Limited$229
  • Nevro Corp.$206
  • Rikco International, LLC$110
  • plus $579 from 13 others

What the payments were for

  • Food & beverage$2,72697%
  • Education$883%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker16$751
Smith+Nephew25$531
Treace Medical Concepts, Inc.9$409
Kerecis Limited4$229
Nevro Corp.10$206
Rikco International, LLC3$110
Johnson & Johnson4$81
Paratek Pharmaceuticals, Inc.4$75
GRT US Holding, Inc.3$74
DJO, LLC4$74
Orthofix Medical, Inc.5$63
Vertex3$57
Accufix Surgical Inc.1$36
Bioventus LLC2$32
Medtronic1$21
Biocomposites Inc1$18
Averitas Pharma Inc.1$18
Convatec Inc.1$17
Alfasigma USA, Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,814 in reported general payments places this provider in the 65th percentile of 46 podiatrist providers in New Mexico.

See all podiatrist providers in New Mexico

Medicare billing

Part B allowed, 2024
$1,015,498
Medicare patients
432
Services billed
3,502

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole116$3,379
Mupirocin118$1,514
Triamcinolone Acetonide107$920
Naproxen35$916
Gabapentin51$703
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen62$579
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav37$506
Cephalexin58$422
Methylprednisolone51$370
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim47$350
Colchicine13$340
Terbinafine Hcl12$279
Allopurinol17$240
Pregabalin17$232
Ibuprofen15$143

Paid to pharmacies, not to this prescriber.

Other podiatrist in Albuquerque

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →